Diapharma/Technozym®vWF:CBA胶原蛋白I ELISA/5450311/Kit/96试验
市场价：
¥0.00
美元价：
0.00
产品分类：
其它检测试剂盒
公司分类：
Other_kits
联系Q Q：
3392242852
电话号码：
4000-520-616
电子邮箱：
info@ebiomall.com
商品介绍
Description:
Technozym®vWF:CBACollagenIELISAisa researchassaykit fordeterminationofvonWillebrandFactor(vWF)collagenbindingactivity(CBA)withcollagenTypIcoatedplates.
KitComposition:
- ELISAteststrips:(12)with8wellseach,coatedwithhumancollagenTypI;thedrying agentissuppliedinanaluminiumbag.
- Washingbufferconcentrate:(PBS;pH7.3);containingdetergent;0.01%merthiolate;1 bottle,80ml.
- Incubationbuffer:(PBS;pH7.3);containsstABIlizerprotein;0.05%proclin;anddye1 bottle,90ml,readyforuse.
- Calibrators:(Standards)numbered;lyophilized;1bottleeach. Concentrationsarelot-dependent;consultlabelonthevial.
- Controlplasmas:“lowlevel”and“highlevel”forcheckingpurposes,lyophilized;1bottle each.Concentrationsarelot-dependent;consultthelabelonthevial.
- Conjugate:polyclonalAnti-vWF-POX;dyedblue;1bottle,0.3ml.
- ChromogenTMB:(tetramethylbenzidine);1bottle,12ml;readytouse.
- Stoppingsolution:sulphuricacid0.45mol/l;1bottle12ml;readyforuse.
- Adhesivefilm:forELISAteststrips(2).
Background:
ThevonWillebrandFactor(vWF)isalarge,multifunctionalglycoprotein,occupyingakey positioninprimaryhemostasis.Ithasamultiplestructurewithseveralfunctions:
- ItisthecarrierproteinforFactorVIIIinplasma;itformsacomplex andthusprotectsFactorVIIIfromearlyproteolyticdecomposition.
- Itactsasamediatorforplateletaggregationbyattachingitselftoplateletmembrane receptors(GPIbandGPlIb/IIIa)followingpreviousplateletactivation.
- Itplaysapartinprimaryhemostasisbyactingasamediatorbetweenadhesionedplatelets andthesubendothelium(lesionedvascularwall).
Inordertoanalyzetheadhesiveproperties,asaruletheplateletaggregationismeasured (measuringsystem=ristocetin-dependentplateletaggregation). However,thisdoesnotreflectthephysiologicalsettingnorthefunctionofthevWF.For determiningtheadhesivepropertiesofthevWF,itsbindingcapacitytocollagenservesasa parameterwhichcorrespondstothephysiologicalfunctionofthevWF.
品牌介绍
Diapharma使命宣言位于俄亥俄州西切斯特的Difarma Group，Inc.在诊断和研究领域销售止血、血栓形成、血小板功能测试、仪器和凋亡产品，并提供强大的技术能力和经验，以确保满足或超过客户的期望。地黄止血显色凝块酶联免疫吸附试验试剂盒历史1997年1月1日，由俄亥俄州富兰克林市的Pharmacia Hepar，Inc.成立，最初是Chromogenix基质和分析的独家美国和加拿大经销商。四分之一个多世纪前，Chromogenix开发了第一个显色底物技术，其前身是Kabi Diagnostica。卡比后来与法玛西亚合并。希帕玛目前的一些员工在法玛西亚肝素制造厂的显色部门工作。1998年，夏帕玛搬到了俄亥俄州的西切斯特，至今仍在那里。多年来，迪法玛扩大了其产品线，包括各种止血、细胞死亡、血小板功能、生态毒理学、化验、试剂、抗体和高级制造商的仪器。2017年，夏帕玛庆祝了20年的成功
